D
David J. Meyer
Researcher at University College London
Publications - 60
Citations - 5489
David J. Meyer is an academic researcher from University College London. The author has contributed to research in topics: Glutathione & Transferase. The author has an hindex of 34, co-authored 60 publications receiving 5430 citations. Previous affiliations of David J. Meyer include Courtauld Institute of Art.
Papers
More filters
Journal ArticleDOI
Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism.
S E Pemble,K R Schroeder,S. R. Spencer,David J. Meyer,E. Hallier,Hermann M. Bolt,Brian Ketterer,J B Taylor +7 more
TL;DR: Characterization of the GSTT1 polymorphism will enable a more accurate assessment of human health risk from synthetic halomethanes and other industrial chemicals.
Journal ArticleDOI
Theta, a new class of glutathione transferases purified from rat and man.
TL;DR: Glutathione transferases of a novel class, which it is proposed to term Theta, were purified from rat and human liver and partial analysis of primary structure shows that subunits 5, 12 and theta are related to each other.
Journal ArticleDOI
The Role of Glutathione in Detoxication
TL;DR: Whether the reaction be enzymic or nonenzymic, conjugation with GSH is a very important means of detoxication accounting in some cases for up to 60% of the biliary metabolites.
Journal ArticleDOI
The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer.
Brian Ketterer,Jonathan M. Harris,Glen Talaska,David J. Meyer,S E Pemble,J B Taylor,Nicholas P. Lang,Fred F. Kadlubar +7 more
TL;DR: In preliminary experiments, described here, with lung tissue from smokers, levels of 32P-postlabeled nuclease P1-enhanced DNA adducts were inversely correlated with levels of antigen cross-reacting with antibody to GSTM1-1, suggesting that initiation depends on the expression of GSTM 1-1.
Journal Article
Purification and characterization of a tumor lipid-mobilizing factor
TL;DR: Evidence is provided that tumor production of Zn-alpha2-glycoprotein is responsible for the lipid catabolism seen in cancer patients, and competitive PCR to quantify expression is found that only those tumors that were capable of producing a decrease in carcass lipid expressed mRNA for Zn